5 completed, 1 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Terminated 1 |
Follow estramustine phosphate sodium: new trials by email Literature Review of estramustine phosphate sodium trials Research Report on estramustine phosphate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer docetaxel, estramustine phosphate sodium, ketoconazole - Prostate Cancer | Phase 3 | Completed | Eastern Cooperative Oncology Group | 2003-10-08 | 2023-06-15 | |
| Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse bicalutamide, Goserelin Acetate, docetaxel - Prostate Cancer | Phase 3 | Completed | UNICANCER | 413 | 2002-11-14 | 2023-01-18 |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer bicalutamide, docetaxel, doxorubicin hydrochloride - Prostate Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 21 | 2002-10-01 | 2020-10-22 |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Docetaxel, Doxorubicin hydrochloride, Estramustine phosphate sodium - Prostate Cancer | Phase 3 | Terminated | M.D. Anderson Cancer Center | 265 | 2002-04-01 | 2016-03-22 |
| Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer bicalutamide, estramustine phosphate sodium, etoposide - Prostate Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 397 | 2000-01-01 | 2020-10-22 |
| Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Bicalutamide, Doxorubicin hydrochloride, Estramustine Phosphate Sodium - Prostate Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 306 | 1996-08-01 | 2018-10-31 |
M.D. Anderson Cancer Center (2) · Radiation Therapy Oncology Group (2) · Eastern Cooperative Oncology Group (1) · UNICANCER (1)
United States (5) · Australia (1) · Canada (1) · France (1) · Peru (1) · Puerto Rico (1)
Gregory P. Swanson, MD (2) · Arif Hussain, MD (1) · Howard M. Sandler, MD (1) · Karim Fizazi, MD, PhD (1) · Kenneth J. Pienta, MD, FACP (1) · Michael A. Carducci, MD (1) · Naomi S. Balzer-Haas, MD (1) · Nirmala Bhoopalam, MD (1) · Primo N. Lara, MD (1) · Randall E. Millikan, MD, PhD (1) · Shi-Ming Tu, MD (1) · William Dahut, MD (1)
PMID 14747052, PMID 16258090, PMID 18990504, PMID 19029421, PMID 22119204, PMID 26028518, PMID 26209502, PMID 36596347
P30CA016672 (2), U10CA045809 (1)